IMMX - Immix Biopharma, Inc.
2.12
0.170 8.019%
Share volume: 25,190
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.95
0.17
0.09%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-12-2024 | 03-24-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 5.590 M | 4.702 M | 7.395 M | 4.987 M | |
| Selling general and admin | 2.341 M | 2.478 M | 2.949 M | 3.613 M | |
| Research and development | 3.249 M | 2.224 M | 4.446 M | 1.374 M | |
| Total expenses | 5.590 M | 4.702 M | 7.395 M | 4.987 M | |
| -15.88% | 57.26% | -32.56% | |||
| Operating income | -5.590 M | -4.702 M | -7.395 M | -4.987 M | |
| Ebit | -5.590 M | -4.702 M | -7.395 M | -4.987 M | |
| Pretax income | -5.322 M | -4.396 M | -7.138 M | -4.801 M | |
| -17.41% | 62.40% | -32.74% | |||
| Income tax | 8.839 K | 10.269 K | 11.144 K | 10.785 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.331 M | -4.406 M | -7.149 M | -4.812 M | |
| 17.36% | -62.27% | 32.69% |
